Good news about Cancer

• 

  Proverbs · October 23, 2026

  Personalized mRNA vaccine cuts melanoma relapse risk by 42%

  An mRNA therapy designed from each patient's own tumor cut the risk of relapse or death by 42% in people who had surgery for melanoma. It is the first phase 3 trial to show this.

By topic

Science Cancer Corals Health mRNA Nature Oceans